Najjam Asghar is Chief Financial Officer of Sorrento Therapeutics, Inc.. Currently has a direct ownership of 56,974 shares of SRNE, which is worth approximately $18,801. The most recent transaction as insider was on Mar 16, 2021, when has been sold 56,974 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57K
0% 3M change
0% 12M change
Total Value Held $18,801

Najjam Asghar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 16 2021
BUY
Grant, award, or other acquisition
-
56,974 Added 50.0%
56,974 Common Stock
NA

Najjam Asghar

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on SRNE

Follow Sorrento Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRNE shares.

Notify only if

Insider Trading

Get notified when an Sorrento Therapeutics, Inc. insider buys or sells SRNE shares.

Notify only if

News

Receive news related to Sorrento Therapeutics, Inc.

Track Activities on SRNE